CAPRELSA for Medullary thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where CAPRELSA was used for Medullary thyroid cancer.
Most Reported Side Effects for CAPRELSA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pancreatitis | 9 | 29.0% | 0 | 9 |
| Renal failure | 7 | 22.6% | 1 | 1 |
| Blood creatinine increased | 5 | 16.1% | 0 | 0 |
| Renal failure acute | 5 | 16.1% | 0 | 5 |
Other Indications for CAPRELSA
Other Drugs Used for Medullary thyroid cancer
VANDETANIB (221)
CABOZANTINIB S-MALATE (165)
SELPERCATINIB (116)
CABOZANTINIB (73)
PRALSETINIB (48)
LENVATINIB (34)
SORAFENIB (18)
OCTREOTIDE (14)
TARLATAMAB-DLLE (13)
SUNITINIB MALATE (11)